⌘K

Login Start Free

Home/Filings/4/0001760460-23-000003

4//SEC Filing

Wang Theodore T 4

Accession 0001760460-23-000003

CIK 0001600132other

View on SEC.gov Company Profile

Filed

May 18, 8:00 PM ET

Accepted

May 19, 8:55 PM ET

Size

10.4 KB

Accession

0001760460-23-000003

Insider Transaction Report

Form 4

Period: 2023-05-18

Bellerophon Therapeutics, Inc.BLPH

Puissance Capital Management LP

10% Owner

Transactions

Sale
Common Stock
2023-05-18$9.46/sh−560,000$5,297,600→ 1,211,262 total

Puissance Life Science Opportunities Fund VI

10% Owner

Transactions

Sale
Common Stock
2023-05-18$9.46/sh−560,000$5,297,600→ 1,211,262 total

Wang Theodore T

Director10% Owner

Transactions

Sale
Common Stock
2023-05-18$9.46/sh−560,000$5,297,600→ 1,211,262 total

Puissance Capital Fund (GP) LLC

10% Owner

Transactions

Sale
Common Stock
2023-05-18$9.46/sh−560,000$5,297,600→ 1,211,262 total

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1

filerCIK 0001694061

Filing Metadata

Form type: 4
Filed: May 18, 8:00 PM ET
Accepted: May 19, 8:55 PM ET
Size: 10.4 KB

View on SEC.gov